Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v6-EN
Language English English
Date Updated 2017-11-16 2017-11-15
Drug Identification Number 00509558 00509558
Brand name EPIPEN EPIPEN
Common or Proper name EPIPEN EPIPEN
Company Name MYLAN SPECIALTY LP MYLAN SPECIALTY LP
Ingredients EPINEPHRINE EPINEPHRINE
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size Each (0.3MG/0.3ML AUTO-INJECTOR) Each (0.3MG/0.3ML AUTO-INJECTOR)
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-10-30 2017-10-30
Estimated end date
Actual end date 2017-11-15 2017-11-15
Shortage status Resolved Actual shortage
Company comments
Health Canada comments